<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01570153</url>
  </required_header>
  <id_info>
    <org_study_id>2012P000312</org_study_id>
    <nct_id>NCT01570153</nct_id>
  </id_info>
  <brief_title>Biomonitoring and Cardiorenal Syndrome in Heart Failure(BIONICS-HF) Trial</brief_title>
  <acronym>BIONICS-HF</acronym>
  <official_title>Biomarkers Plus Bioimpedance Vector Analysis to Predict Cardiorenal Syndrome Onset and Prognosis in Patients With Acutely Decompensated Heart Failure: Biomonitoring and Cardiorenal Syndrome in Heart Failure(BIONICS-HF) Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the ability of a non-invasive monitor that measures
      how much fluid is in the body as well as various blood tests for their ability to predict
      worsening kidney function in patients with heart failure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our specific aims are to:

        1. Evaluate the individual and collective ability of pro-B type natriuretic peptide
           (NT-pro-BNP), soluble (s)ST2, neutrophil gelatinase-associated lipocalin (NGAL), and
           bioelectrical impedance vector analysis (BIVA) for predicting in-hospital worsening
           renal function (WRF) in patients evaluated in emergency department (ED)with acutely
           decompensated heart failure (ADHF)compared to a model of clinical variables alone.

        2. Evaluate the individual and collective ability of NT-proBNP, sST2, NGAL, and BIVA for
           identifying the correct cause of in-hospital WRF in patients evaluated in the ED with
           ADHF.

        3. Evaluate the individual and collective ability of NT-pro-BNP, sST2, NGAL, and BIVA for
           predicting outcomes (all-cause death, all-cause re-hospitalization, initiation of renal
           replacement therapy by 180 days) in patients with ADHF.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the onset of Worsening renal function following admission</measure>
    <time_frame>From beginning of hospitalization to a follow up of 60 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>the initiation of renal replacement therapy</measure>
    <time_frame>From beginning of hospitalization to a follow up of 60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>all cause mortality</measure>
    <time_frame>From beginning of hospitalization to a follow up of 60 days</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Cardiorenal Syndrome</condition>
  <condition>Acute Decompensated Heart Failure</condition>
  <arm_group>
    <arm_group_label>ADHF patients</arm_group_label>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      10 ml sample of blood will be draw into a tube containing ethylenediaminetetraacetic acid,
      spun for 15 minutes, and aliquoted to freezer tubes for biomarker measurement following the
      completition of the trial
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting to the Emergency Department of the Massachusetts General Hospital with
        complaints compatible with Acute Decompensated Heart Failure (ADHF)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Dyspnea thought to be due to ADHF

          -  NYHA class III or IV symptoms

        Exclusion Criteria:

          -  renal failure requiring renal replacement therapy rior to enrollment

          -  unable or unwilling to participate

          -  &gt; 6 hours from first dose of intravenous diuretic
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James L Januzzi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cardiology Division/Cardiac Unit Associated Director Cardiac Care Unit</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Sant'Andrea</name>
      <address>
        <city>Rome</city>
        <zip>00189</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL Jr. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol. 2006 Jan 3;47(1):91-7. Epub 2005 Dec 9.</citation>
    <PMID>16386670</PMID>
  </reference>
  <reference>
    <citation>Manzano-Fernández S, Januzzi JL Jr, Boronat-Garcia M, Bonaque-González JC, Truong QA, Pastor-Pérez FJ, Muñoz-Esparza C, Pastor P, Albaladejo-Otón MD, Casas T, Valdés M, Pascual-Figal DA. β-trace protein and cystatin C as predictors of long-term outcomes in patients with acute heart failure. J Am Coll Cardiol. 2011 Feb 15;57(7):849-58. doi: 10.1016/j.jacc.2010.08.644.</citation>
    <PMID>21310322</PMID>
  </reference>
  <reference>
    <citation>van Kimmenade RR, Januzzi JL Jr, Baggish AL, Lainchbury JG, Bayes-Genis A, Richards AM, Pinto YM. Amino-terminal pro-brain natriuretic Peptide, renal function, and outcomes in acute heart failure: redefining the cardiorenal interaction? J Am Coll Cardiol. 2006 Oct 17;48(8):1621-7. Epub 2006 Sep 27.</citation>
    <PMID>17045898</PMID>
  </reference>
  <reference>
    <citation>van Kimmenade RR, Pinto Y, Januzzi JL Jr. When renal and cardiac insufficiencies intersect: is there a role for natriuretic peptide testing in the 'cardio-renal syndrome'? Eur Heart J. 2007 Dec;28(24):2960-1. Epub 2007 Nov 5.</citation>
    <PMID>17984131</PMID>
  </reference>
  <reference>
    <citation>Ronco C, McCullough PA, Anker SD, Anand I, Aspromonte N, Bagshaw SM, Bellomo R, Berl T, Bobek I, Cruz DN, Daliento L, Davenport A, Haapio M, Hillege H, House A, Katz NM, Maisel A, Mankad S, Zanco P, Mebazaa A, Palazzuoli A, Ronco F, Shaw A, Sheinfeld G, Soni S, Vescovo G, Zamperetti N, Ponikowski P; Acute Dialysis Quality Initiative (ADQI) consensus group. Cardiorenal syndromes: an executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol. 2010;165:54-67. doi: 10.1159/000313745. Epub 2010 Apr 20.</citation>
    <PMID>20427956</PMID>
  </reference>
  <reference>
    <citation>Tang WH, Mullens W. Cardiorenal syndrome in decompensated heart failure. Heart. 2010 Feb;96(4):255-60. doi: 10.1136/hrt.2009.166256. Epub 2009 Apr 27. Review.</citation>
    <PMID>19401280</PMID>
  </reference>
  <reference>
    <citation>Dupont M, Shrestha K, Tang WH. Revisiting the cardio-renal hypothesis: the pivotal role of the kidney in congestive heart failure. Eur J Heart Fail. 2011 Aug;13(8):820-2. doi: 10.1093/eurjhf/hfr092.</citation>
    <PMID>21791537</PMID>
  </reference>
  <reference>
    <citation>Gottlieb SS, Abraham W, Butler J, Forman DE, Loh E, Massie BM, O'connor CM, Rich MW, Stevenson LW, Young J, Krumholz HM. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail. 2002 Jun;8(3):136-41.</citation>
    <PMID>12140805</PMID>
  </reference>
  <reference>
    <citation>Maisel AS, Mueller C, Fitzgerald R, Brikhan R, Hiestand BC, Iqbal N, Clopton P, van Veldhuisen DJ. Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial. Eur J Heart Fail. 2011 Aug;13(8):846-51. doi: 10.1093/eurjhf/hfr087.</citation>
    <PMID>21791540</PMID>
  </reference>
  <reference>
    <citation>Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WH. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009 Feb 17;53(7):589-96. doi: 10.1016/j.jacc.2008.05.068.</citation>
    <PMID>19215833</PMID>
  </reference>
  <reference>
    <citation>Mullens W, Abrahams Z, Skouri HN, Francis GS, Taylor DO, Starling RC, Paganini E, Tang WH. Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol. 2008 Jan 22;51(3):300-6. doi: 10.1016/j.jacc.2007.09.043.</citation>
    <PMID>18206740</PMID>
  </reference>
  <reference>
    <citation>Shah RV, Chen-Tournoux AA, Picard MH, van Kimmenade RR, Januzzi JL. Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea. Circ Heart Fail. 2009 Jul;2(4):311-9. doi: 10.1161/CIRCHEARTFAILURE.108.833707. Epub 2009 May 14.</citation>
    <PMID>19808354</PMID>
  </reference>
  <reference>
    <citation>Januzzi JL Jr, Peacock WF, Maisel AS, Chae CU, Jesse RL, Baggish AL, O'Donoghue M, Sakhuja R, Chen AA, van Kimmenade RR, Lewandrowski KB, Lloyd-Jones DM, Wu AH. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study. J Am Coll Cardiol. 2007 Aug 14;50(7):607-13. Epub 2007 Jul 30.</citation>
    <PMID>17692745</PMID>
  </reference>
  <reference>
    <citation>Rehman SU, Martinez-Rumayor A, Mueller T, Januzzi JL Jr. Independent and incremental prognostic value of multimarker testing in acute dyspnea: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Clin Chim Acta. 2008 Jun;392(1-2):41-5. doi: 10.1016/j.cca.2008.03.002. Epub 2008 Mar 13.</citation>
    <PMID>18387360</PMID>
  </reference>
  <reference>
    <citation>Rehman SU, Mueller T, Januzzi JL Jr. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure. J Am Coll Cardiol. 2008 Oct 28;52(18):1458-65. doi: 10.1016/j.jacc.2008.07.042.</citation>
    <PMID>19017513</PMID>
  </reference>
  <reference>
    <citation>Nickolas TL, O'Rourke MJ, Yang J, Sise ME, Canetta PA, Barasch N, Buchen C, Khan F, Mori K, Giglio J, Devarajan P, Barasch J. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med. 2008 Jun 3;148(11):810-9.</citation>
    <PMID>18519927</PMID>
  </reference>
  <reference>
    <citation>Singer E, Elger A, Elitok S, Kettritz R, Nickolas TL, Barasch J, Luft FC, Schmidt-Ott KM. Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes. Kidney Int. 2011 Aug;80(4):405-14. doi: 10.1038/ki.2011.41. Epub 2011 Mar 16.</citation>
    <PMID>21412214</PMID>
  </reference>
  <reference>
    <citation>Piccoli A. Bioelectric impedance measurement for fluid status assessment. Contrib Nephrol. 2010;164:143-52. doi: 10.1159/000313727. Epub 2010 Apr 20.</citation>
    <PMID>20428000</PMID>
  </reference>
  <reference>
    <citation>Di Somma S, De Berardinis B, Bongiovanni C, Marino R, Ferri E, Alfei B. Use of BNP and bioimpedance to drive therapy in heart failure patients. Congest Heart Fail. 2010 Jul;16 Suppl 1:S56-61. doi: 10.1111/j.1751-7133.2010.00162.x.</citation>
    <PMID>20653713</PMID>
  </reference>
  <reference>
    <citation>Peacock WF 4th. Use of bioimpedance vector analysis in critically ill and cardiorenal patients. Contrib Nephrol. 2010;165:226-35. doi: 10.1159/000313762. Epub 2010 Apr 20.</citation>
    <PMID>20427973</PMID>
  </reference>
  <reference>
    <citation>Piccoli A, Pittoni G, Facco E, Favaro E, Pillon L. Relationship between central venous pressure and bioimpedance vector analysis in critically ill patients. Crit Care Med. 2000 Jan;28(1):132-7.</citation>
    <PMID>10667512</PMID>
  </reference>
  <reference>
    <citation>Parrinello G, Paterna S, Di Pasquale P, Torres D, Fatta A, Mezzero M, Scaglione R, Licata G. The usefulness of bioelectrical impedance analysis in differentiating dyspnea due to decompensated heart failure. J Card Fail. 2008 Oct;14(8):676-86. doi: 10.1016/j.cardfail.2008.04.005. Epub 2008 Jun 6.</citation>
    <PMID>18926440</PMID>
  </reference>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2012</study_first_submitted>
  <study_first_submitted_qc>April 2, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2012</study_first_posted>
  <last_update_submitted>March 21, 2014</last_update_submitted>
  <last_update_submitted_qc>March 21, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 24, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>James L. Januzzi</investigator_full_name>
    <investigator_title>JANUZZI, JAMES L, MD CARDIOLOGY DIVISION CARDIAC UNIT ASSOCIATES DIRECTOR CARDIAC CARE UNIT</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Cardio-Renal Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

